نتایج جستجو برای: multiplex ligation dependentprobe amplification

تعداد نتایج: 97340  

2015
Xingyuan Ling Hai Long Guang Pan Zhinan Chen

ABI PRISM 3100 Genetic Analyzer, a multi-color fluorescence-based DNA analysis system with 16 capillaries operating in parallel, was ideal tool both for DNA sequencing and DNA fragment analysis [1,2]. To demonstrate the effectiveness and reliability of an asymmetric PCR-Based approach (X.Y. Ling, G.M. Zhang, G. Pan, H. Long, Y.H. Cheng, C.Y. Xiang, L. Kang, F. Chen, Z.N. Chen, Preparing long pr...

2016
Kushal Shrestha Smita Shrestha Saroj Khatiwada Bishnu Acharya Sulochana Manandhar Rohit Kumar

Duchenne muscular dystrophy (DMD) is X-linked recessive neuromuscular disorders caused due to mutation in dystrophin gene, leading to progressive muscle weakness. This study was done to identify mutation in dystrophin gene in Nepalese patients with DMD using Multiplex Ligation Dependent Probe Amplification (MLPA) assay in Nepal. Twenty one patients from different regions of Nepal, who were clin...

2013
Yvonne Chekaluk Chin-Lee Wu Jonathan Rosenberg Markus Riester Qishan Dai Sharron Lin Yanan Guo W. Scott McDougal David J. Kwiatkowski

We performed a genome wide analysis of 164 urothelial carcinoma samples and 27 bladder cancer cell lines to identify copy number changes associated with disease characteristics, and examined the association of amplification events with stage and grade of disease. Multiplex inversion probe (MIP) analysis, a recently developed genomic technique, was used to study 80 urothelial carcinomas to ident...

2017
Robbert D.A. Weren Arjen R. Mensenkamp Michiel Simons Astrid Eijkelenboom Aisha S. Sie Hicham Ouchene Monique van Asseldonk Encarna B. Gomez‐Garcia Marinus J. Blok Joanne A. de Hullu Marcel R. Nelen Alexander Hoischen Johan Bulten Bastiaan B.J. Tops Nicoline Hoogerbrugge Marjolijn J.L. Ligtenberg

With the recent introduction of Poly(ADP-ribose) polymerase inhibitors, a promising novel therapy has become available for ovarian carcinoma (OC) patients with inactivating BRCA1 or BRCA2 mutations in their tumor. To select patients who may benefit from these treatments, assessment of the mutation status of BRCA1 and BRCA2 in the tumor is required. For reliable evaluation of germline and somati...

Journal: :Haematologica 2009
Marion Phylipsen Antonio Amato Maria Pia Cappabianca Jan Traeger-Synodinos Emmanuel Kanavakis Nazli Basak Renzo Galanello Teresa Tuveri Giovanni Ivaldi Cornelis L Harteveld Piero C Giordano

When the molecular background of couples requesting prevention is unclear, family analysis and tools to define rare mutations are essential. We report two novel deletion defects observed in an Italian and in a Turkish couple. The first proband presented with microcytic hypochromic parameters without iron deficiency, a normal HbA(2) and an elevated HbF (10.6%). His father presented with a simila...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید